Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Dapagliflozin 10 mg's trials
Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.
Dapagliflozin 10 mg
Unknown
Unknown
Phase 4
Open NCT02919059 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
